|Day's range||14.60 - 14.60|
Here's why they chose Axsome Therapeutics (NASDAQ: AXSM), Johnson & Johnson (NYSE: JNJ), and Pfizer (NYSE: PFE) as opportunities that especially stand out. Prosper Junior Bakiny (Axsome Therapeutics): Last year, Axsome Therapeutics' share price doubled, partly due to the FDA approving its depression medicine Auvelity for use. The company's stock is down by 19% since the start of the year.
Investing in top COVID-19 vaccine maker Pfizer (NYSE: PFE) seems like it should have made you rich if you bought the stock in March 2020. On March 2, 2020, Pfizer's stock was selling for $33 a share. It would be nearly a year before Pfizer had an approved COVID-19 vaccine, which was produced in partnership with BioNTech.
High-quality dividend stocks can be a great way to tilt the odds in your favor as an investor. The core reason is that top-shelf dividend stocks generally have a long-standing shareholder base due to the reliability of their payouts.